We are live on ! Find out more
TCMP

Thrive Capital Management (Pennsylvania) Portfolio holdings

AUM $530M
1-Year Est. Return 22.41%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+22.41%
3 Year Est. Return
+58.21%
5 Year Est. Return
+53.58%
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$21.6M
Cap. Flow
+$17.1M
Cap. Flow %
13.27%
Top 10 Hldgs %
37.42%
Holding
115
New
9
Increased
66
Reduced
26
Closed
6

Top Buys

Rank Stock Value
1
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$1.87M
2
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$1.5M
3
AOM icon
iShares Core Moderate Allocation ETF
AOM
+$1.43M
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$1.34M
5
CVX icon
Chevron
CVX
+$1.09M

Top Sells

Rank Stock Value
1
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$1.59M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.16M
3
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$1.01M
4
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$946K
5
GSK icon
GSK
GSK
+$920K

Sector Composition

Rank Sector Weight
1 Technology 8.7%
2 Healthcare 7.05%
3 Consumer Staples 3.65%
4 Consumer Discretionary 2.99%
5 Communication Services 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
101
Exelon
EXC
$47B
$257K 0.2%
8,129
-744
-8% -$23.9K
NEE icon
102
NextEra Energy
NEE
$177B
$254K 0.2%
+3,468
New +$260K
VYM icon
103
Vanguard High Dividend Yield ETF
VYM
$82.8B
$244K 0.19%
2,330
– –
SPYM
104
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$237K 0.18%
4,711
-2,028
-30% -$99.5K
MRSH
105
Marsh
MRSH
$91.5B
$234K 0.18%
1,663
– –
BSV icon
106
Vanguard Short-Term Bond ETF
BSV
$44.6B
$223K 0.17%
2,714
-227
-8% -$18.7K
XOM icon
107
ExxonMobil
XOM
$634B
$218K 0.17%
+3,458
New +$206K
PFE icon
108
Pfizer
PFE
$153B
$216K 0.17%
+5,518
New +$215K
IVW icon
109
iShares S&P 500 Growth ETF
IVW
$77.6B
$201K 0.16%
+2,768
New +$192K
BWZ icon
110
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$270M
– –
-18,537
Closed -$584K
ELD icon
111
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
– –
-13,373
Closed -$428K
GSK icon
112
GSK
GSK
$106B
– –
-20,618
Closed -$920K
IGIB icon
113
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
– –
-4,950
Closed -$293K
IJR icon
114
iShares Core S&P Small-Cap ETF
IJR
$112B
– –
-2,642
Closed -$287K
SCHF icon
115
Schwab International Equity ETF
SCHF
$68.7B
– –
-14,142
Closed -$266K
1 2 3 4
5

Similar funds

UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s Q2 2021 Portfolio in Review

As of Q2 2021, Thrive Capital Management (Pennsylvania) held 115 positions worth $129M, up 20% from $107M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Thrive Capital Management (Pennsylvania) deployed $17.1M of net new capital in Q2 2021, opening 9 new positions and adding to 66 existing holdings. Its largest new stake was Chevron: 10,341 shares worth $1.08M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.5% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $1.59M trimmed.

  • Thrive Capital Management (Pennsylvania)'s largest Q2 2021 buy was Chevron: 10,341 shares worth $1.08M.
  • Thrive Capital Management (Pennsylvania) added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q2 2021, an estimated $1.87M increase.
  • Thrive Capital Management (Pennsylvania)'s biggest Q2 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $1.59M.
  • Thrive Capital Management (Pennsylvania) fully exited GSK in Q2 2021, selling an estimated $920K.
  • Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 37% of its $129M portfolio in Q2 2021.
  • Thrive Capital Management (Pennsylvania) opened 9 new positions and closed 6 in Q2 2021.
  • Thrive Capital Management (Pennsylvania)'s portfolio value rose 20% quarter-over-quarter to $129M.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2021, filed 6 Aug 2021.